The application belongs to the technical field of medical
organic synthesis, and particularly relates to a preparation method of an
oxazole ester compound. The
oxazole ester compound is prepared by using N-ethoxyoxalyl-alpha-
alanine ethyl ester (
oxalate) as a starting material, adding a catalytic amount of
rare earth cerium trichloride as a catalyst under the action of
triphenylphosphine dichloride and an
organic base, and promoting a chloro-
cycloaddition reaction by using a
rare earth coordination effect. The obtained
oxazole ester can be further subjected to
saponification and
decarboxylation to obtain a
vitamin B6 intermediate 4-methyl-5-ethyloxazole. The
reaction rate is significantly accelerated and the reaction yield is improved by using the coordination effect of the
rare earth cerium trichloride, the amount of the
cerium trichloride is as low as 0.003%, and the
cerium trichloride is easy to recover. The process does not need to use
imidazole compounds as a catalyst, and the problem of difficult
recovery of
imidazole is avoided. The process is green,
environmentally friendly, safe, simple and convenient to operate, the yield and purity of the target product are high, and the process is suitable for industrial production.